Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Andrx Plans Diltiazem ANDA Amendment In May; Biovail Delists Tiazac Patent

Apr 15 2002

• By The Pink Sheet

Related Content

AHP K-Dur Settlement With FTC Applies To Brand And Generic Divisions

Feb 25 2002

Upsher Launches K-Dur Generic With Exclusivity; FTC Hearing In December

Sep 10 2001

Biovail Says Tiazac Andrx Settlement “Satisfies” FTC; Patent Remains Listed

Feb 25 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window